OAM
VANI icon

Oxford Asset Management’s Vivani Medical VANI Stock Holding History

Oxford Asset Management’s Portfolio VANI Stock Details VANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-5,891
Closed -$836K – 900
2015
Q4 		$836K Buy
+5,891
New +$862K 0.02% 576

Other funds holding VANI

HCS
Harvest Capital Strategies San Francisco, California $73.7M AUM 7.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Oxford Asset Management's VANI Position: Q1 2016 in Review

Oxford Asset Management sold out of Vivani Medical (VANI) in Q1 2016, closing a stake of 5,891 shares — an estimated $836K sold.

Oxford Asset Management first reported a position in VANI in Q4 2015 and held it in 1 quarter. The position peaked at $836K in Q4 2015. 57 funds tracked by Wall St. Rank hold VANI as of Q1 2016.

  • Oxford Asset Management reported no remaining Vivani Medical position as of Q1 2016 after selling out during the quarter.
  • Oxford Asset Management sold 5,891 Vivani Medical shares in Q1 2016, an estimated $836K.
  • Oxford Asset Management first reported a position in Vivani Medical in Q4 2015 and held it in 1 quarter.
  • Oxford Asset Management's Vivani Medical position peaked at $836K in Q4 2015.
  • 57 funds tracked by Wall St. Rank held Vivani Medical as of Q1 2016.

Based on Oxford Asset Management's 13F filing for Q1 2016, filed 9 May 2016.